Structures by: Marjo C.
Total: 13
C13H24ClN5
C13H24ClN5
CrystEngComm (2017)
a=5.0652(13)Å b=10.017(3)Å c=15.742(4)Å
α=97.550(16)° β=97.678(15)° γ=99.715(15)°
C9H16ClN5
C9H16ClN5
CrystEngComm (2017)
a=5.1163(11)Å b=10.011(2)Å c=12.451(2)Å
α=93.943(9)° β=96.452(9)° γ=100.613(9)°
C13H24ClN5
C13H24ClN5
CrystEngComm (2017)
a=5.120(13)Å b=10.14(3)Å c=17.37(5)Å
α=91.51(5)° β=93.57(5)° γ=101.03(4)°
C11H20ClN5
C11H20ClN5
CrystEngComm (2017)
a=5.0858(6)Å b=10.0093(10)Å c=15.2007(18)Å
α=104.518(5)° β=92.842(6)° γ=100.832(5)°
C9H16ClN5
C9H16ClN5
CrystEngComm (2017)
a=10.280(4)Å b=10.351(3)Å c=12.987(4)Å
α=98.30(2)° β=112.37(2)° γ=108.27(3)°
C7H11ClN5,C4H7
C7H11ClN5,C4H7
CrystEngComm (2017)
a=5.0839(11)Å b=10.0172(19)Å c=15.237(3)Å
α=104.473(14)° β=92.935(15)° γ=100.729(13)°
C7H10Cl2N4
C7H10Cl2N4
CrystEngComm (2017)
a=5.0120(10)Å b=11.794(2)Å c=17.086(3)Å
α=86.52(3)° β=84.11(3)° γ=82.67(3)°
C8H12Cl2N4
C8H12Cl2N4
CrystEngComm (2017)
a=25.548(5)Å b=5.0000(10)Å c=19.343(4)Å
α=90° β=115.30(3)° γ=90°
C39H57N7O3
C39H57N7O3
Dalton Trans. (2017)
a=13.6115(19)Å b=13.6115(19)Å c=35.291(7)Å
α=90° β=90° γ=120°
1(C39H54Gd1N7O3),1(C39H51Gd1N7O3),4(H2O)
1(C39H54Gd1N7O3),1(C39H51Gd1N7O3),4(H2O)
Dalton Trans. (2017)
a=12.3620(18)Å b=12.3620(18)Å c=31.321(6)Å
α=90° β=90° γ=120°
1(C39H54Eu1N7O3),1.5(H2O)
1(C39H54Eu1N7O3),1.5(H2O)
Dalton Trans. (2017)
a=12.3525(17)Å b=12.3525(17)Å c=31.422(6)Å
α=90° β=90° γ=120°
Duloxetine hydrochloride
C18H20NOS,Cl
Acta Crystallographica Section E (2009) 65, 9 o2294
a=9.7453(10)Å b=6.9227(7)Å c=13.4247(16)Å
α=90.00° β=109.432(4)° γ=90.00°
C39H54Dy1N7O3,3(H2O)
C39H54Dy1N7O3,3(H2O)
Dalton Trans. (2017)
a=12.3876(10)Å b=12.3876(10)Å c=31.693(3)Å
α=90° β=90° γ=120°